KENNEDY SPACE CENTER, Fla., December 15, 2021 (CASIS PR) – The microgravity environment on the International Space Station (ISS) has a profound impact on cells and tissues, allowing researchers to conduct life sciences research in ways not possible on the ground. SpaceX’s 24th Commercial Resupply Services (CRS) mission to the orbiting laboratory will deliver a variety of life science payloads sponsored by the ISS National Lab. From stem cell research on neurodegenerative diseases to a tissue chip experiment studying the blood-brain barrier and an investigation testing the use of bacteria to protect DNA from the stresses of spaceflight—the research launching on this mission is helping to improve the quality of life for people on Earth.

KENNEDY SPACE CENTER, Fla., December 13, 2021 (CASIS PR) – SpaceX’s upcoming 24th Commercial Resupply Services (CRS) mission to the International Space Station (ISS) will include more than 15 payloads sponsored by the ISS National Laboratory, managed by the Center for the Advancement of Science in Space, Inc. (CASIS). These payloads include multiple investigations from private-sector entities, including two supported by highly recognizable companies: Merck and Procter & Gamble.

KENNEDY SPACE CENTER, Fla. (NASA PR) — The 24^thSpaceX cargo resupply services mission, targeted to launch in late December from NASA’s Kennedy Space Center in Florida, carries scientific research and technology demonstrations to the International Space Station. The experiments aboard include studies of bioprinting, crystallization of monoclonal antibodies, changes in immune function, plant gene expression changes, laundering clothes in space, processing alloys, and student citizen science projects.